I'm not aware of any analysts that had revenue contribution from Hernia in FY21. Perhaps some very small (100's k) in FY22 and only modest (low single digit millions) in FY23.
So today's announcement not much of a surprise to analysts IMO.
By then BTM sales will likely be around 90-100m pa.
PNV - Banter and General Comments, page-4971
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.55 |
Change
0.175(7.38%) |
Mkt cap ! $1.766B | |||
| Open | High | Low | Value | Volume |
| $2.44 | $2.60 | $2.44 | $5.332M | 2.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9678 | $2.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 20712 | 13 |
View Market Depth
| Last trade - 12.06pm 17/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |